Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |||||
---|---|---|---|---|---|
First Received Date † | May 10, 2007 | ||||
Last Updated Date | April 17, 2008 | ||||
Start Date † | May 2007 | ||||
Current Primary Outcome Measures † |
Precision at the contralateral arms using the average residual coefficient of variation over subsequent linear regressions (detrending) over time | ||||
Original Primary Outcome Measures † | Same as current | ||||
Change History | Complete list of historical versions of study NCT00472121 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures † |
|
||||
Original Secondary Outcome Measures † | Same as current | ||||
Descriptive Information | |||||
Brief Title † | The Precision and Arm-to-Arm Variation of Mechanomyography and Acceleromyography for Monitoring of Neuromuscular Block | ||||
Official Title † | The Precision and Arm-to-Arm Variation og Mechanomyography and Acceleromyography for Monitoring the Neuromuscular Block During Anesthesia, A Randomized Controlled Study | ||||
Brief Summary | The purpose of the study is the examine the precision of acceleromyography and mechanomyography during recovery from a neuromuscular blocking agent and to examine whether there is any difference in monitoring block at the dominant or non-dominant arm. Our hypothesis is that there is no significant difference in neither the precision nor the level of block in the contralateral arms. |
||||
Detailed Description | |||||
Study Phase | Phase IV | ||||
Study Type † | Observational | ||||
Study Design † | |||||
Condition † | Neuromuscular Blockade | ||||
Intervention † | Device: TOF-Watch SX (neuromuscular monitor) | ||||
Study Arms / Comparison Groups | |||||
Publications * | |||||
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status † | Completed | ||||
Enrollment † | |||||
Completion Date | October 2007 | ||||
Primary Completion Date | October 2007 (final data collection date for primary outcome measure) | ||||
Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
||||
Gender | Both | ||||
Ages | 18 Years to 65 Years | ||||
Accepts Healthy Volunteers | |||||
Contacts †† | |||||
Location Countries † | Denmark | ||||
Expanded Access Status | |||||
Administrative Information | |||||
NCT ID † | NCT00472121 | ||||
Responsible Party | |||||
Secondary IDs †† | |||||
Study Sponsor † | Rigshospitalet, Denmark | ||||
Collaborators †† | |||||
Investigators † |
|
||||
Information Provided By | Rigshospitalet, Denmark | ||||
Verification Date | April 2008 | ||||
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |